NBSTRN Summit Day 1 at 12pm EST Curt Scharfe

Newborn Screening Translational Research Network (NBSTRN) Newborn Screening Summit on Sept 8-10, 2020.

NBSTRN Summit Day 1 at 12pm EST with Curt Scharfe, MD, PhD
Dr. Scharfe presented "Reducing False-Positive Results in Newborn Metabolic Screening using Machines Learning"

Dr. Curt Scharfe is an Associate Professor of Genetics at the Yale School of Medicine. He obtained his medical degree from the University of Frankfurt and a PhD in biomedical sciences from the University of Wurzburg. He completed his residency in pediatrics and medical genetics at the University of Munich Children’s Hospital, and his fellowship in clinical molecular genetics at Stanford University with board certification by the American Board of Medical Genetics and Genomics (ABMGG) in 2017. As a DFG postdoctoral fellow with Ronald Davis at Stanford University, he developed technology based on functional genomics screening, transcriptomics, and mass-spectrometry proteomics to identify hundreds of nuclear-encoded mitochondrial protein genes.

Be informed. Be transformed with new research.

Please follow us and tag us on social media @NBSTRN Facebook, Instagram, Pinterest, Twitter, and LinkedIn.

This project has been funded in whole or in part with Federal funds from the NICHD, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201800005C.